JP Morgan Chase
SANA icon

JP Morgan Chase’s Sana Biotechnology SANA Stock Holding History

JP Morgan Chase’s Portfolio SANA Stock Details SANA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.68M Sell
777,298
-8,536
-1% -$27.5K ﹤0.01% 3970
2026
Q1 		$2.11M Sell
785,834
-29,621
-4% -$117K ﹤0.01% 4060
2025
Q4 		$3.32M Sell
815,455
-1,319,989
-62% -$5.91M ﹤0.01% 3681
2025
Q3 		$7.58M Buy
2,135,444
+1,375,029
+181% +$4.97M ﹤0.01% 2969
2025
Q2 		$2.08M Sell
760,415
-44,749
-6% -$92.3K ﹤0.01% 3891
2025
Q1 		$1.35M Sell
805,164
-1,471
-0.2% -$4.11K ﹤0.01% 4145
2024
Q4 		$1.31M Sell
806,635
-110,538
-12% -$330K ﹤0.01% 4439
2024
Q3 		$3.82M Sell
917,173
-34,391
-4% -$181K ﹤0.01% 3424
2024
Q2 		$5.2M Sell
951,564
-153,923
-14% -$1.23M ﹤0.01% 3006
2024
Q1 		$11.1M Sell
1,105,487
-85,147
-7% -$638K ﹤0.01% 2386
2023
Q4 		$4.86M Buy
1,190,634
+13,302
+1% +$49K ﹤0.01% 3112
2023
Q3 		$4.56M Sell
1,177,332
-60,466
-5% -$325K ﹤0.01% 2912
2023
Q2 		$7.38M Sell
1,237,798
-1,204,505
-49% -$6.94M ﹤0.01% 2554
2023
Q1 		$7.99M Buy
2,442,303
+66,301
+3% +$265K ﹤0.01% 2478
2022
Q4 		$9.38M Sell
2,376,002
-3,710
-0.2% -$18.1K ﹤0.01% 2320
2022
Q3 		$14.3M Sell
2,379,712
-115,602
-5% -$834K ﹤0.01% 1858
2022
Q2 		$16M Buy
2,495,314
+9,535
+0.4% +$60.7K ﹤0.01% 1792
2022
Q1 		$20.5M Buy
2,485,779
+469,673
+23% +$3.8M ﹤0.01% 1751
2021
Q4 		$31.2M Buy
2,016,106
+390,684
+24% +$7.53M ﹤0.01% 1476
2021
Q3 		$36.6M Buy
1,625,422
+370,123
+29% +$7.77M ﹤0.01% 1346
2021
Q2 		$24.7M Sell
1,255,299
-269,713
-18% -$6.11M ﹤0.01% 1664
2021
Q1 		$51M Buy
+1,525,012
New +$49.7M 0.01% 1155

Other funds holding SANA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.54B AUM 86.39% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $181B AUM 41.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
MG
Marex Group London $23.6B AUM 57.16% 1-Year Est. Return

JP Morgan Chase's SANA Position: Q2 2026 in Review

JP Morgan Chase reduced its Sana Biotechnology (SANA) stake by 1.1% in Q2 2026, selling an estimated $27.5K and leaving 777,298 shares worth $2.68M. The position accounts for ﹤0.01% of the portfolio, ranked #3970.

JP Morgan Chase first reported a position in SANA in Q1 2021 and has held it in 22 quarters since. The position peaked at $51M in Q1 2021. 211 funds tracked by Wall St. Rank hold SANA as of Q2 2026.

  • JP Morgan Chase held 777,298 shares of Sana Biotechnology worth $2.68M as of Q2 2026.
  • JP Morgan Chase sold 8,536 Sana Biotechnology shares in Q2 2026, an estimated $27.5K.
  • Sana Biotechnology made up ﹤0.01% of JP Morgan Chase's portfolio in Q2 2026, its #3970 holding.
  • JP Morgan Chase first reported a position in Sana Biotechnology in Q1 2021 and has held it in 22 quarters since.
  • JP Morgan Chase's Sana Biotechnology position peaked at $51M in Q1 2021.
  • 211 funds tracked by Wall St. Rank held Sana Biotechnology as of Q2 2026.

Based on JP Morgan Chase's 13F filing for Q2 2026, filed 12 Aug 2026.